Search
for

    Did you mean International Prostate Symptom Score?
    Glossary International Prostate Symptom Score

    standardized questionnaire assessing urinary symptoms and quality of life

    The International Prostate Symptom Score (IPSS) is a standardized questionnaire used to evaluate the severity of symptoms related to benign prostatic hyperplasia (BPH), a common condition in older men where the prostate gland enlarges and causes urinary problems. The IPSS consists of seven questions about urinary symptoms and one question about the patient's quality of life, helping healthcare providers assess the impact of BPH on daily activities and guide treatment decisions.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial Prostate International · 2023 · 1 citations
    2. Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial The World Journal of Men s Health · 2023 · 5 citations
    3. Serenoa repens (Saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part I Uro · 2021 · 2 citations
    4. Efficacy and Safety of Thermobalancing Therapy in Men with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia was Confirmed by Clinical Trial ARC Journal of Urology · 2016 · 1 citations
    5. Efficacy and Safety of a Proprietary Free Fatty Acid Rich Saw Palmetto Extract (USPlus<sup>®</sup> PRO) for Lower Urinary Tract Symptoms in Males: A Randomized, Double-Blind, Placebo-Controlled Trial Food and Nutrition Sciences · 2026
    6. The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study 2002 · 110 citations
    7. Doxazosin and finasteride alone or in combination: the PREDICT study BJUI · 2003 · 3 citations
    8. Androgenetic alopecia as an early marker of benign prostatic hyperplasia Journal of The American Academy of Dermatology · 2011 · 28 citations
    9. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    10. The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men Food Reviews International · 2018 · 15 citations
    11. Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature Archivio Italiano di Urologia e Andrologia · 2020 · 14 citations
    12. Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia The Journal of Urology · 2012 · 5 citations
    13. Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial Molecular genetics and metabolism · 2019 · 3 citations
    14. Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 3 citations
    15. Glatze in jungen Jahren könnte Risikofaktor für BPH sein Uro-News · 2012
    16. Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    17. Comparative Study of Therapeutic Effect of Dibenyline, Finasteride, and Combination Drugs for Symptomatic Benign Prostatic Hyperplasia Urologia internationalis · 1998 · 21 citations
    18. Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial African Journal of Urology · 2024 · 1 citations
    19. Efficacy of Combination of Tamsulosin and Finasteride on Urinary Symptoms and IPSS Score for Elderly Patients with BPH Hebei yixue · 2014
    20. SHPro <sup>®</sup> (mixture of <i>Angelica gigas</i> and <i>Astragalus membranaceus</i> ) in men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled clinical trial Investigative and Clinical Urology · 2025
    21. Relación entre los síntomas del tracto urinario bajo y las características anatómicas de la próstata en pacientes con obesidad y obesidad grave Cirugía y cirujanos · 2020
    22. Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia LUTS Lower Urinary Tract Symptoms · 2024
    23. UP-02.009 Clinical Significance of Intravesical Prostatic Protrusion/Prostate Volume Urology · 2011
    24. Efficacy and safety of long-term administration of tamsulosin hydrochloride in patients with LUTS suggestive of BPH Zhonghua miniao waike zazhi · 2010
    25. 1262 ONE YEAR FINASTERIDE THERAPY IN MEN WITH A SERUM PSA GREATER THAN 4 NG/ML WHO HAD UNDERGONE REPEAT BIOPSY The Journal of Urology · 2012
    26. 1747 PREDICTION OF BLADDER PROSTATIC OBSTRUCTION: DEVELOPMENT OF A SIMPLIFIED CLINICAL NOMOGRAM The Journal of Urology · 2013
    27. Association of Benign Prostatic Hyperplasia with Male Pattern Baldness Urology · 1998 · 54 citations
    28. Оптимизация подходов консервативной терапии доброкачественной гиперплазии предстательной железы ингибиторами 5-альфаредуктазы. Клинико-морфологическое исследование Курский научно-практический вестник "Человек и его здоровье" · 2012
    29. Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction Hormone Molecular Biology and Clinical Investigation · 2017 · 20 citations
    30. Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms. PubMed · 2019 · 1 citations